These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2292315)

  • 1. [Basic and experimental studies of the renin-angiotensin-aldosterone system in diabetes mellitus].
    Katayama S
    Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1243-7. PubMed ID: 2292315
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal renin-angiotensin-aldosterone system in streptozotocin-diabetic rats.
    Nakayama T; Izumi Y; Soma M; Kanmatsuse K
    Horm Metab Res; 1998 Jan; 30(1):12-5. PubMed ID: 9503033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of renin-angiotensin-aldosterone in experimental diabetes mellitus.
    Ustündag B; Cay M; Naziroglu M; Dilsiz N; Crabbe MJ; Ilhan N
    Cell Biochem Funct; 1999 Sep; 17(3):193-8. PubMed ID: 10451540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats.
    Choi KC; Kim NH; An MR; Kang DG; Kim SW; Lee J
    Kidney Int Suppl; 1997 Sep; 60():S23-7. PubMed ID: 9285898
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system in diabetes mellitus.
    Christlieb AR
    Diabetes; 1976; 25(2 SUPPL):820-5. PubMed ID: 823063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
    Giacchetti G; Sechi LA; Rilli S; Carey RM
    Trends Endocrinol Metab; 2005 Apr; 16(3):120-6. PubMed ID: 15808810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin-angiotensin-aldosterone system in diabetes mellitus (author's transl)].
    Matsuda S; Itazu T
    Nihon Naika Gakkai Zasshi; 1981 Apr; 70(4):525-33. PubMed ID: 7288238
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
    Tikellis C; Cooper ME; Thomas MC
    Int J Biochem Cell Biol; 2006; 38(5-6):737-51. PubMed ID: 16198140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type1 diabetes.
    Toba H; Mitani T; Takahashi T; Imai N; Serizawa R; Wang J; Kobara M; Nakata T
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1064-70. PubMed ID: 20678154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Sowers JR
    J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renin-angiotensin system in diabetes mellitus].
    Kuczera M; Klin M
    Pol Tyg Lek; 1993 Jan 4-11; 48(1-2):39-42. PubMed ID: 8361883
    [No Abstract]   [Full Text] [Related]  

  • 18. The renin-angiotensin system in the endocrine pancreas.
    Carlsson PO
    JOP; 2001 Jan; 2(1):26-32. PubMed ID: 11862019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The renin-angiotensin-aldosterone system in diabetics].
    Kokot F
    Pol Tyg Lek; 1978 Jul; 33(31):1235-6. PubMed ID: 358169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.